comparemela.com

Latest Breaking News On - Metabolic anticancer - Page 1 : comparemela.com

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

/PRNewswire/ Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.